NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

PROOF-Registry New and Extended Belgium -Luxembourg

CompletedN/A

Sponsor: Belgian Thoracic Society

Conditions: Idiopathic Pulmonary Fibrosis

Countries: Belgium, Luxembourg

A Prospective Observational Registry to describe the disease course and outcomes of Idiopathic Pulmonary Fibrosis patients in a real-world clinical setting.

Eligibility overview

Sex: ALL

Age: 19 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Patients \>18 years of age
* IPF diagnosis "definite" or "probable" (2011 ATS/ERS guidelines definitions) confirmed by a multidisciplinary team (= minimum of pulmonologist, radiologist, pathologist, all with expertise in IPF).
* Patients who agreed to participate in the registry and have completed and signed the Informed Consent Form

Exclusion Criteria:

* Patients incapable of giving informed consent
* Patients participating in a clinical trial at the time of inclusion in the registry and whose protocol does not allow participation in another trial

Locations (9)

Antwerp, Belgium
Brussels, Belgium
Brussels, Belgium
Ghent, Belgium
Leuven, Belgium
Liège, Belgium
Liège, Belgium
Yvoir, Belgium
Luxembourg, Luxembourg